You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Egypt

Nov 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Growth boosted by emergent mid-income group

There was a strong current value growth for overall consumer health during the review period. Growth was linked to emergence in the country’s mid-income group and also to a growing focus on health and hygiene. A growing focus on hygiene encouraged many to trade up from unpackaged herbs to packaged consumer health. A growing focus on health meanwhile resulted in many consumers becoming more proactive in their approach to health, with this trend particularly boosting sales of vitamins and dietary supplements.

Sales hindered by legislative environment and limited distribution

A number of factors however hindered sales growth for consumer health during the review period and in 2011. Strong UTC sales and the limited number of OTC products hindered sales throughout the review period. Only a handful of product areas are classified as OTC, while chemists/pharmacies routinely sell Rx medicines without requesting a prescription. Analgesics, calming and sleeping, ear care and many other products were entirely classified as Rx medicines in Egypt during the review period and were thus excluded from the scope of this report. Limited distribution and tight controls on advertising for the majority of products also hindered sales growth, with almost all products sold exclusively via chemists/pharmacies.

Price controls and 2011 revolution also impact growth

Current value sales growth was also hindered by government price controls on medicines, with these lacking any link to inflation. With high inflation in Egypt during the review period, constant value sales declined sharply for most product areas during the review period. Many players were forced to reduce their product ranges and to focus only on higher-margin products as they sought to maintain profit margins and survive. Growth was also hindered by the revolution in 2011, which resulted in growing price-sensitivity and disrupted distribution. However, growth rates remained steady in 2011 thanks to strong demand among health-conscious mid-income consumers

Domestic players continue to lead

While GlaxoSmithKline ranked second in consumer health in 2011, the majority of the leading positions were accounted for by domestic players such as Amriya, Pharcoa and Amoun. This is due to a number of factors. Domestic players are typically more skilled at negotiating the government’s complicated and time-consuming registration system for medicines. They are also better able to cope with strict price controls, due to their lower-cost domestic distribution. They also have strong distribution networks in Egypt, which enabled them to maintain a steady distribution presence even during the unrest seen in 2011. With low prices and a strong distribution presence in 2011, most of the leading domestic players further gained share in the year.

Health-awareness to drive growth in forecast period

Consumer health is expected to see a strong constant value performance during the forecast period. Growth will continue to be underpinned by consumers’ growing focus on health and hygiene, with consumers taking more responsibility for leading healthy lives and also trading up from unpackaged herbs to packaged consumer health. Constant value growth could also be supported by the government revising price controls for some areas. Price controls could well become linked to inflation or removed for value-added products during the forecast period. In addition, as the post-revolution government reforms the country it is expected to focus on reforming the healthcare system, which could well result in the reclassification of many medicines from Rx to OTC in the long-term.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Egypt with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Egypt, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Egypt for free:

The Consumer Health in Egypt market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Egypt?
  • What are the major brands in Egypt?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Egypt - Industry Overview

EXECUTIVE SUMMARY

Growth boosted by emergent mid-income group

Sales hindered by legislative environment and limited distribution

Price controls and 2011 revolution also impact growth

Domestic players continue to lead

Health-awareness to drive growth in forecast period

KEY TRENDS AND DEVELOPMENTS

Lack of differentiation between OTC, Rx and UTC sales

Strong competition from herbal/traditional products

Internet retailing offers an alternative to chemists/pharmacies

Revolution has little impact on sales thanks to emerging mid-income group

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

DEFINITIONS

SOURCES

  • Summary 1 Research Sources

Consumer Health in Egypt - Company Profiles

Amoun Pharmaceutical Industry Co in Consumer Health (Egypt)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 3 Amoun Pharmaceutical Industry Co: Competitive Position 2011

Egyptian International Pharmaceutical Industries Co SAE (EIPICO) in Consumer Health (Egypt)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 6 Egyptian International Pharmaceutical Industries Co SAE (EIPICO): Competitive Position 2011

Pharco Pharmaceuticals in Consumer Health (Egypt)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Pharco Pharmaceuticals: Competitive Position 2011

Adult Mouth Care in Egypt - Category Analysis

HEADLINES

TRENDS

  • Growth in adult mouth care was mainly linked to growing consumer awareness of oral hygiene issues in Egypt. This was in turn linked to strong growth for the country’s mid-income group during the review period as a whole. Consequently, while sales growth slowed in 2011 as a result of the revolution and economic uncertainty, it remained good at 9%. This was due to mid- and high-income consumers being less impacted by high inflation, low wages and the country’s instability. Growth however dipped in comparison to a review period current value CAGR of 18%.

SWITCHES

COMPETITIVE LANDSCAPE

  • Egyptian International Pharmaceutical Industries Co SAE (EIPICO) and Amoun Pharmaceutical were the clear leaders in adult mouth care at the end of the review period, accounting for 20% and 18% value share respectively. These companies benefit from offering the Tantum Verde and Oracure brands respectively, with these brands having wide distribution and affordable prices.

PROSPECTS

  • Adult mouth care is expected to see a reasonable constant value and volume CAGR of 3% during the forecast period. Growth will continue to be underpinned by widening awareness and will be largely driven by leading players EIPICO and Amoun. While EIPICO will boost awareness by widening its distribution via supermarkets and hypermarkets, Amoun will continue to promote its brand to pharmacists and thus increase product recommendations for adult mouth care. Growth is also expected to be supported by consumers’ growing interest in health and hygiene.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2006-2011
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 13 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 14 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Egypt - Category Analysis

HEADLINES

TRENDS

  • There are no OTC analgesics available in Egypt for legal sale without a prescription. All analgesics are classified as Rx medicines in the country and are thus excluded from the scope of this research.

SWITCHES

COMPETITIVE LANDSCAPE

  • No analgesics brands are classified as OTC in Egypt, with all brands being classified as Rx. However, chemists/pharmacies typically sell analgesics UTC without requesting a prescription.

PROSPECTS

  • Egypt saw revolution in 2011 with the creation of a new president in 2012. The country is currently formulating a new constitution, although it faces considerable political instability. Once the country has returned to political stability, the government is likely to instigate major reforms of the healthcare system. These are likely to simplify and clarify the registration of medicines and to dramatically expand the range of medicines classified as OTC. Analgesics could thus be reclassified as OTC during the forecast period. However, given the instability seen in Egypt in 2012 and the major reforms required for the healthcare system in general, such a reclassification is not expected before 2015 at the earliest.

Calming and Sleeping in Egypt - Category Analysis

HEADLINES

TRENDS

  • All calming and sleeping available in Egypt are classified as Rx medicines and are thus not legally available for purchase without a prescription. Despite this, these products are widely available via chemists/pharmacies via UTC sales. As Rx medicines, calming and sleeping are however excluded from the scope of this report.

SWITCHES

COMPETITIVE LANDSCAPE

  • There are no OTC brands available in calming and sleeping in Egypt.

PROSPECTS

  • Major healthcare reforms are required in Egypt. However, these are unlikely to be completed swiftly, with the new Egyptian government facing instability, challenges to its authority and ongoing unrest in 2012. Consequently, the introduction of OTC calming and sleeping is not likely prior to the second half of the forecast period and may well not occur until after the forecast period.

Cough, Cold and Allergy (Hay Fever) Remedies in Egypt - Category Analysis

HEADLINES

TRENDS

  • Volume growth was dynamic for the review period as a whole thanks to strong growth in Egypt’s mid-income group. Growth slowed in 2011 due to the impact of the 2011 revolution, with many consumers becoming more careful in their spending patterns. However, volume growth remained strong, with the leading product areas cough remedies and medicated confectionery for example seeing 6% and 8% volume growth respectively. This was largely thanks to ongoing sales growth to mid-income consumers but was also linked to ongoing government price controls.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sigma Pharmaceutical Industries was the clear leader in cough, cold and allergy (hay fever) remedies in 2011 with 32% value share. The company offers a range of successful brands, with its strongest being Balsam in cough remedies. This brand led cough remedies with 19% value share in the year and also led overall cough, cold and allergy (hay fever) remedies with 14% share. The brand has strong consumer awareness in Egypt and is the obvious choice for many Egyptians when treating coughs.

PROSPECTS

  • Cough, cold and allergy (hay fever) remedies is expected to continue to be hindered at the start of the forecast period by the limited range of products classified as OTC in Egypt. There is a strong case for many Rx products to be switched to OTC, given that these products are widely sold UTC in chemists/pharmacies. Switching would clarify the product environment in cough, cold and allergy (hay fever) remedies, particularly if stricter controls were imposed on Rx sales. However, the Egyptian government continued to face numerous challenges at the start of the forecast period and reforms are required in many areas of the country’s healthcare system. Consequently, a major overhaul of Rx and OTC classifications in cough, cold and allergy (hay fever) remedies is unlikely until towards the end of the forecast period.

CATEGORY DATA

  • Table 17 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 19 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 20 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 21 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 22 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 24 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Egypt - Category Analysis

HEADLINES

TRENDS

  • The 2011 revolution had only a slight impact on sales of digestive remedies in the year. Growth slowed slightly in current value terms, dropping from a review period CAGR of 13% to 12%. However, growth rates remained strong, with this linked to ongoing strict price controls. While high inflation resulted in soaring prices for most fast-moving consumer goods in Egypt, price controls for medicines are not inflation-linked. Antacids and paediatric indigestion and heartburn remedies, the sole two product areas in OTC digestive remedies, thus saw 10% constant value unit price decline in 2011 over the previous year and 44% decline for the review period as a whole. This enabled consumers to continue to buy these products, although it put heavy pressure on producers’ profit margins.

SWITCHES

COMPETITIVE LANDSCAPE

  • Pharco Pharmaceuticals was the clear leader in digestive remedies in 2011, accounting for 35% of overall value sales. The company benefits from offering a wide range of brands in this product area, although the bulk of its sales stem from its Fawar brand in antacids and from Gripe Baby Water in paediatric indigestion and heartburn remedies. These brands have a long history in Egypt and enjoy strong customer loyalty. Fawar also benefits from being sold in low-priced small sachets, making it affordable to all income groups, while Gripe Baby Water is also offered at a low price.

PROSPECTS

  • Digestive remedies will continue to be hindered by a limited OTC product range at the start of the forecast period and by strong UTC sales of Rx products. Only antacids are classified as OTC in this product area. The new Egyptian government created in 2012 is likely to reform the country’s healthcare system if it survives into the long-term. However, the government must first return the country to economic and political stability, while healthcare reforms are also likely to be far-reaching and slowly implemented. Consequently, the switching of a wider range of digestive remedies to OTC status is unlikely until the second half of the forecast period at the earliest.

CATEGORY DATA

  • Table 25 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 26 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 27 Digestive Remedies Company Shares by Value 2007-2011
  • Table 28 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 29 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 30 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Egypt - Category Analysis

HEADLINES

TRENDS

  • All ear care is categorised as Rx medicine in Egypt, with no presence for OTC products. Rx products meanwhile fall beyond the scope of this report.

SWITCHES

COMPETITIVE LANDSCAPE

  • There are no OTC brands of ear care available in Egypt.

PROSPECTS

  • Egypt embarked upon the forecast period with a new president and government and plans for a new constitution. However, political instability and unrest continued to be seen in 2012 and the new government faces many areas where there is a need for reform. Healthcare reforms are required in the country but reforms are expected to be major. Consequently, a reform of the OTC classification process is not expected until towards the end of the forecast period and could well not occur until after this time. It is therefore possible but unlikely that OTC ear care will emerge during the forecast period.

Eye Care in Egypt - Category Analysis

HEADLINES

TRENDS

  • Eye care is classified as Rx in Egypt and thus may only legally be sold with a prescription. Rx eye care is excluded from the scope of this report, while OTC eye care is thus insignificant.

SWITCHES

COMPETITIVE LANDSCAPE

  • There are no OTC brands of eye care present in Egypt, with all eye care being classified as Rx.

PROSPECTS

  • The future of eye care remains uncertain in Egypt. Major healthcare reforms are required in the country. However, the government faced more urgent issues at the start of the forecast period, with political instability and unrest continuing throughout 2012. Consequently, reforms to OTC classifications are unlikely to be seen before 2015. There is a possibility that eye care will be switched to OTC status towards the end of the forecast period but the process of reforms may well take longer.

Herbal/Traditional Products in Egypt - Category Analysis

HEADLINES

TRENDS

  • Sales of herbal/traditional products benefited from a growing focus on hygiene in Egypt during the review period, particularly among mid- and high-income consumers. Consequently, many consumers switched from unpackaged herbs to packaged herbal/traditional products. This trend was linked to the emergence of a larger mid-income group in the country and also to growing media coverage of the dangers of contaminated or poor quality herbs. Consequently, sales continued to see strong growth in 2011 over the previous year, despite the impact of the revolution in this year on consumers’ purchasing habits in general. Growth reached 14% in current value terms in 2011 over the previous year, up from a review period CAGR of 11%.

COMPETITIVE LANDSCAPE

  • Sigma Pharmaceutical Industries was the clear leader in herbal/traditional products in 2011 and accounted for 22% value share, more than double the share of its leading competitor Pharaonia Pharmaceutical. Sigma benefits from its strength in herbal/traditional cough, cold and allergy (hay fever) remedies, where its Balsam brand in particular enjoys strong consumer awareness and wide distribution. This brand is the first choice for many consumers when treating coughs and alone accounted for 10% value share in herbal/traditional products in 2011.

PROSPECTS

  • Herbal/traditional cough, cold and allergy (hay fever) remedies is expected to see sales decline during the forecast period, with volume and constant value sales declining by 11% overall. This product area is expected to suffer from consumers switching to standard OTC and Rx medicine as their disposable income levels rise, believing standard products to be more effective. In addition, this product area will continue to face strong competition from unpackaged herbs and traditional remedies, particularly among low-income consumers and those in rural areas.

CATEGORY DATA

  • Table 31 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 32 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 33 Herbal/Traditional Products Company Shares 2007-2011
  • Table 34 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 35 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 36 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Egypt - Category Analysis

HEADLINES

TRENDS

  • Egypt saw a high and increasing birth rate during the review period, with the birth rate rising from 25.5 births per 1,000 inhabitants in 2006 to 28.5 births by 2011. This fuelled strong growth in the potential consumer base for nappy (diaper) rash treatments. While the revolution in 2011 resulted in a slight drop in the birth rate in the year, it remained considerably higher than that seen at the start of the review period.

SWITCHES

COMPETITIVE LANDSCAPE

  • Medical Union Pharmaceuticals and Amoun Pharmaceutical Industry were the leading players in medicated skin care in 2011, accounting for 21% value share each thanks to their Zinc Olive and Baby Cream brands of nappy (diaper) rash treatments. These brands benefit from their low price, wide distribution and long presence in Egypt.

PROSPECTS

  • Any major switches within medicated skin care are unlikely to be seen much before the end of the forecast period. The government will instead focus on addressing ongoing political instability in Egypt at the start of the forecast period. Consequently, nappy (diaper) rash treatments is expected to remain the only significant product area in OTC medicated skin care, at least at the start of the forecast period. Other product areas, while sold UTC in most chemists/pharmacies, will continue to be classified as Rx and thus excluded from the scope of this report.

CATEGORY DATA

  • Table 37 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 38 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 39 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 40 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 41 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 42 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Egypt - Category Analysis

HEADLINES

TRENDS

  • NRT smoking cessation aids remained insignificant in Egypt at the end of the review period. There is little awareness of or demand for these products and there is also little distribution presence for these products in chemists/pharmacies.

SWITCHES

COMPETITIVE LANDSCAPE

  • There are no significant brands or companies that have a consistent and significant distribution presence in NRT smoking cessation aids in Egypt.

PROSPECTS

  • Consumer attitudes to smoking will have to be changed before NRT smoking cessation aids will become a significant product area in Egypt. Consumer education campaigns alerting consumers to the dangers of smoking could well result in a widening desire to quit. However, the Egyptian government had many other pressing matters to attend to at the start of the forecast period, such as strong calls for higher minimum wage levels and ongoing political instability and unrest. Anti-smoking campaigns are thus unlikely until the country has returned to stability and the government has addressed a number of the country’s other significant problems.

Sports Nutrition in Egypt - Category Analysis

HEADLINES

TRENDS

  • Sales of sports nutrition continued to be insignificant at the end of the review period. There is little consumer awareness of these products and distribution remains limited. The high price of these products further hinders sales, with most Egyptians being unable to afford sports nutrition. These products are mainly sold in gyms and health clubs targeting high-income consumers. Players are unwilling to push for wider distribution due to a lack of consumer interest.

COMPETITIVE LANDSCAPE

  • There were no clear leaders in sports nutrition at the end of the review period. These products are typically privately imported by gyms and health clubs, with a wide and fluctuating range of brands thus being available.

PROSPECTS

  • Sports nutrition is not expected to see strong sales growth during the forecast period due to a number of factors. Firstly, interest in body-building is strongest among young low-income men, a group characterised by high unemployment levels or low wages. High prices for sports nutrition meanwhile result in this group being unable to afford these products.

Vitamins and Dietary Supplements in Egypt - Category Analysis

HEADLINES

TRENDS

  • There was a growing interest in health and wellness in Egypt during the review period, with urban mid- and high-income consumers in particular becoming more proactive in improving their health. This trend was particularly strong among women. Consumers became increasingly aware of nutrients such as vitamin B and calcium thanks to media coverage and word-of-mouth recommendations, with many of those who began to take vitamins and dietary supplements urging their friends and family to do likewise.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Amriya for Pharmaceutical Industries led sales of vitamins and dietary supplements in 2011 with a value share of 11%. The company benefits from a wide product range, although the bulk of its sales stem from Depovit B12, with this being the leading brand in overall vitamins and dietary supplements and alone accounting for 7% value share. This brand is widely used by women trying to conceive and those in the first trimester of pregnancy. The brand benefits from wide distribution and from strong word-of-mouth and pharmacist recommendations.

PROSPECTS

  • The consumption of vitamins and dietary supplements is expected to continue to be differentiated by income group during the forecast period, with different income groups driving sales growth for different product areas. Mid- and high-income consumers in Egypt are expected to continue to become more health-conscious during the forecast period, with these consumers thus becoming better educated about a widening range of vitamins and dietary supplements. These consumers are for example likely to support 9% constant value CAGR in both garlic and echinacea during the forecast period.

CATEGORY DATA

  • Table 43 Table11 Dietary Supplements: Brand Ranking by Positioning 2011
  • Table 44 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 45 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 46 Dietary Supplements by Positioning 2006-2011
  • Table 47 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 48 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 49 Vitamins Brand Shares by Value 2008-2011
  • Table 50 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 51 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 52 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Egypt - Category Analysis

HEADLINES

TRENDS

  • Weight management is a new product area in Egypt, with slimming teas gaining significant sales for the first time in 2009. This is the only significant product area in weight management. Sales growth was strong in 2011, reaching 15% in volume terms and 22% in current value terms. Growth was supported by widening distribution for these products, which are not included in medicines according to Egyptian legislation and can thus be distributed via non-pharmacy channels. Widening distribution via supermarkets and hypermarkets thus boosted consumers’ awareness of these products.

COMPETITIVE LANDSCAPE

  • Weight management was entirely accounted for by slimming teas at the end of the review period. Slimming teas was meanwhile dominated by Ottoman, which thus accounted for 52% value share in overall weight management with its Royal brand in 2011. Ottoman benefits from a strong reputation for quality and from its use of organic herbs. It also benefits from its domestic production in Giza, which enabled the company to maintain a strong distribution presence even during the unrest of 2011. The company consequently saw a strong growth in value share in the year, gaining 16 percentage points.

PROSPECTS

  • Slimming teas is expected to benefit from a growing focus on health and slimness among mid- and high-income women during the forecast period. These products are expected to benefit from widening awareness among this group, thanks to expanded distribution via supermarkets and hypermarkets and also thanks to strong word-of-mouth recommendations. These consumers are likely to be attracted to these products as a shortcut in the long and laborious process of weight loss. Consequently, slimming teas is expected to see a strong 10% constant value CAGR and 11% volume CAGR during the forecast period.

CATEGORY DATA

  • Table 53 Sales of Weight Management: Value 2009-2011
  • Table 54 Sales of Weight Management: % Value Growth 2009-2011
  • Table 55 Weight Management Company Shares 2007-2011
  • Table 56 Weight Management Brand Shares 2008-2011
  • Table 57 Forecast Sales of Weight Management: Value 2011-2016
  • Table 58 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in Egypt - Category Analysis

HEADLINES

TRENDS

  • Wound care continued to be hindered by the widespread sale of single plasters in chemists/pharmacies. These outlets typically sell cheap unpackaged plasters singly, with consumers purchasing these products according to need. With widespread poverty in Egypt, most consumers prefer to buy sticking plasters as needed and in small quantities.

COMPETITIVE LANDSCAPE

  • Pharmaplast was the dominant player within wound care throughout the review period and accounted for 50% value share in 2011. This company offers three strong brands in wound care, with Cure Aid, Silkplast and Doctor Aid accounting for 26%, 20% and 4% value share respectively in 2011. These brands benefited from a consistent distribution presence throughout the review period, wide distribution via chemists/pharmacies and affordable prices.

PROSPECTS

  • Wound care is expected to continue to benefit from consumers’ growing hygiene concerns during the forecast period. There will be growing awareness of the need for sterile dressings when attending to wounds and of the benefits of dressing wounds rapidly following injury. Consequently, consumers are expected to increasingly trade up from buying single sticking plasters/adhesive bandages as needed to keeping a box of these products in their home in case of injury. This trend will also be encouraged by the ongoing emergence of Egypt’s mid-income group as the country returns to political stability.

CATEGORY DATA

  • Table 59 Sales of Wound Care by Category: Value 2006-2011
  • Table 60 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 61 Wound Care Company Shares by Value 2007-2011
  • Table 62 Wound Care Brand Shares by Value 2008-2011
  • Table 63 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 64 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
              • Bee Pollen
              • Yeast
        • Tonics and Bottled Nutritive Drinks
        • Vitamins
          • Multivitamins
          • Single Vitamins
            • Vitamin A
            • Vitamin B
            • Vitamin C
            • Vitamin D
            • Vitamin E
            • Other Single Vitamins
      • Weight Management
        • Meal Replacement Slimming
        • OTC Obesity
        • Slimming Teas
        • Weight Loss Supplements
        • Other Slimming Products
      • Herbal/Traditional Products
        • Herbal/Traditional Analgesics
        • Herbal/Traditional Calming and Sleeping Products
        • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
        • Herbal/Traditional Digestive Remedies
        • Herbal/Traditional Medicated Skin Care
        • Herbal/Traditional Medicinal Teas
        • Herbal/Traditional Smoking Cessation Aids
        • Herbal/Traditional Paediatric Dietary Supplements
        • Herbal/Traditional Dietary Supplements
        • Herbal/Traditional Tonics and Bottled Nutritive Drinks
      • Allergy Care
        • Allergy Eye Care
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Allergy Remedies
        • Topical Allergy Remedies/Antihistamines
      • Paediatric Consumer Health
        • Paediatric Analgesics
          • Paediatric Acetaminophen
          • Paediatric Aspirin
          • Paediatric Combination Products - Analgesics
          • Paediatric Diclofenac
          • Paediatric Dipyrone
          • Paediatric Ibuprofen
          • Paediatric Ketoprofen
          • Paediatric Naproxen
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Paediatric Medicated Skin Care
        • Nappy (Diaper) Rash Treatments
        • Paediatric Vitamins and Dietary Supplements

    Statistics Included

    Statistics Included

    For each category and subcategory you will receive the following data in Excel format:

    From Passport

    • Market sizes
    • Company shares
    • Brand shares
    • Distribution
    • Analysis by positioning
    • Herbal/traditional vs standard
    • Pricing
    • Smoking population - number of adult smokers
    • Smoking prevalence - % of adult population

    Market size details:

    • Retail volume
    • Retail volume % growth
    • Retail volume per capita
    • Retail value retail selling price % growth
    • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price % growth
    • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

    Methodology

    Methodology

    Global insight and local knowledge

    With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

    This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

    Industry specialists

    Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

    Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

    The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

    Country and regional analysts

    Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

    In-country research network

    To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

    Research Methodology

    Our research methods

    Each Euromonitor International industry report is based on a core set of research techniques:

    Desk research

    With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

    • National statistics offices governmental and official sources
    • National and international trade press
    • National and international trade associations
    • Industry study groups and other semi-official sources
    • Company financials and annual reports
    • Broker reports
    • Online databases
    • The financial, business and mainstream press

    Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

    Store checks

    Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

    • Place: We track products in all relevant channels, selective and mass, store and non-store
    • Product: What are innovations in products, pack sizes and formats?
    • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
    • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

    Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

    Trade survey

    Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

    Trade surveys allow us to:

    • Fill gaps in available published data per company
    • Generate a consensus view of the size, structure and strategic direction of the category
    • Access year-in-progress data where published sources are out of date
    • Evaluate the experts’ views on current trends and market developments

    In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

    Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

    Company analysis

    At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

    At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

    Forecasts

    Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

    Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

    Data validation

    All data is subjected to an exhaustive review process, at country, regional and global levels.

    The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

    Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

    Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

    Market analysis

    Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

    Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

    my pages

    Want to find out more about this report?

    If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!